These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 11887871)

  • 21. Stability of the peritoneal membrane in long-term peritoneal dialysis patients.
    Selgas R; Bajo MA; Paiva A; Del Peso G; Diaz C; Aguilera A; Hevia C
    Adv Ren Replace Ther; 1998 Jul; 5(3):168-78. PubMed ID: 9686627
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Membrane viability in the long-term peritoneal dialysis patient.
    Schreiber MJ
    Perit Dial Int; 1997; 17 Suppl 3():S19-24. PubMed ID: 9304652
    [No Abstract]   [Full Text] [Related]  

  • 23. The pathophysiology of the peritoneal membrane.
    Devuyst O; Margetts PJ; Topley N
    J Am Soc Nephrol; 2010 Jul; 21(7):1077-85. PubMed ID: 20448020
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Factors increasing severity of peritonitis in long-term peritoneal dialysis patients.
    Park MS
    Adv Ren Replace Ther; 1998 Jul; 5(3):185-93. PubMed ID: 9686629
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ultrafiltration failure in CAPD.
    Shetty A; Oreopoulos DG
    J Postgrad Med; 1994; 40(3):185-93. PubMed ID: 8699390
    [No Abstract]   [Full Text] [Related]  

  • 26. [Anatomic-functional correlation of the peritoneal membrane].
    del Peso G; Jiménez-Hefferman JA; Bajo MA; Sánchez-Villanueva R; Tabernero A; Aroeira L; Selgas R
    Nefrologia; 2008; 28 Suppl 6():11-6. PubMed ID: 18957006
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Peritoneal transport in long-term peritoneal dialysis patients and its relation with AGEs.
    Feriani M
    Contrib Nephrol; 2001; (131):74-81. PubMed ID: 11125565
    [No Abstract]   [Full Text] [Related]  

  • 28. Evaluation of ultrafiltration failure.
    Korbet SM
    Adv Ren Replace Ther; 1998 Jul; 5(3):194-204. PubMed ID: 9686630
    [TBL] [Abstract][Full Text] [Related]  

  • 29. TGF-β1-VEGF-A pathway induces neoangiogenesis with peritoneal fibrosis in patients undergoing peritoneal dialysis.
    Kariya T; Nishimura H; Mizuno M; Suzuki Y; Matsukawa Y; Sakata F; Maruyama S; Takei Y; Ito Y
    Am J Physiol Renal Physiol; 2018 Feb; 314(2):F167-F180. PubMed ID: 28978530
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular mechanisms involved in the peritoneal membrane exposed to peritoneal dialysis.
    Devuyst O
    Nefrologia; 2003; 23 Suppl 3():32-7. PubMed ID: 12901190
    [No Abstract]   [Full Text] [Related]  

  • 31. Prevention and treatment of peritoneal dialysis membrane failure.
    Krediet RT
    Adv Ren Replace Ther; 1998 Jul; 5(3):212-7. PubMed ID: 9686632
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Peritoneal dialysis: a biological membrane with a nonbiological fluid.
    Witowski J; Jörres A
    Contrib Nephrol; 2009; 163():27-34. PubMed ID: 19494592
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Peritoneal membrane structural and functional changes during peritoneal dialysis.
    Goffin E
    Semin Dial; 2008; 21(3):258-65. PubMed ID: 18363601
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mesenchymal conversion of mesothelial cells as a mechanism responsible for high solute transport rate in peritoneal dialysis: role of vascular endothelial growth factor.
    Aroeira LS; Aguilera A; Selgas R; Ramírez-Huesca M; Pérez-Lozano ML; Cirugeda A; Bajo MA; del Peso G; Sánchez-Tomero JA; Jiménez-Heffernan JA; López-Cabrera M
    Am J Kidney Dis; 2005 Nov; 46(5):938-48. PubMed ID: 16253736
    [TBL] [Abstract][Full Text] [Related]  

  • 35. AGE accumulation in peritoneal membrane and cavity during peritoneal dialysis and its effect on peritoneal structure and function.
    Park MS; Lee HB
    Perit Dial Int; 1999; 19 Suppl 2():S53-7. PubMed ID: 10406494
    [No Abstract]   [Full Text] [Related]  

  • 36. The renin-angiotensin-aldosterone system in peritoneal dialysis: is what is good for the kidney also good for the peritoneum?
    Nessim SJ; Perl J; Bargman JM
    Kidney Int; 2010 Jul; 78(1):23-8. PubMed ID: 20336052
    [TBL] [Abstract][Full Text] [Related]  

  • 37. L-2-oxothiazolidine-4-carboxylate: an agent that modulates lipopolysaccharide-induced peritonitis in rats.
    Korybalska K; Wieczorowska-Tobis K; Polubinska A; Wisniewska J; Moberly J; Martis L; Breborowicz A; Oreopoulos DG
    Perit Dial Int; 2002; 22(3):293-300. PubMed ID: 12227385
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Angiogenesis in peritoneal dialysis.
    Stavenuiter AW; Schilte MN; Ter Wee PM; Beelen RH
    Kidney Blood Press Res; 2011; 34(4):245-52. PubMed ID: 21691127
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Peritoneal dialysis: how to improve peritoneal permeability or function.
    Krediet RT; Ho-dac-Pannekeet M; Smit W; Zweers MM; Struijk DG
    Adv Nephrol Necker Hosp; 1997; 27():167-88. PubMed ID: 9408447
    [No Abstract]   [Full Text] [Related]  

  • 40. Peritoneum: a noble membrane in long-term dialysis treatment.
    Barone RJ; Campora MI; Gimenez NS; Ramirez L; Santopietro M; Grbavac D; Pattin M; Panese SA
    Adv Perit Dial; 2009; 25():80-4. PubMed ID: 19886323
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.